Patents by Inventor Neal M. Farber

Neal M. Farber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9433616
    Abstract: The invention provides methods and compositions comprising an anti-cholinergic agent for decreasing saliva production and treating sialorrhea.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: September 6, 2016
    Assignee: NeuroHealing Pharmaceuticals, Inc.
    Inventors: Marcelo Merello, Neal M. Farber, Eyal S. Ron
  • Publication number: 20160067233
    Abstract: The invention provides methods and compositions comprising an anti-cholinergic agent for decreasing saliva production and treating sialorrhea.
    Type: Application
    Filed: November 19, 2015
    Publication date: March 10, 2016
    Applicant: NeuroHealing Pharmaceuticals, Inc.
    Inventors: Marcelo Merello, Neal M. Farber, Eyal S. Ron
  • Patent number: 9198897
    Abstract: The invention provides methods and compositions comprising an anti-cholinergic agent for decreasing saliva production and treating sialorrhea.
    Type: Grant
    Filed: January 19, 2006
    Date of Patent: December 1, 2015
    Assignee: NeuroHealing Pharmaceuticals, Inc.
    Inventors: Marcelo Merello, Neal M. Farber, Eyal S. Ron
  • Publication number: 20110306669
    Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.
    Type: Application
    Filed: August 22, 2011
    Publication date: December 15, 2011
    Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu
  • Patent number: 7943632
    Abstract: Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual apomorphine. Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual at least 1000 mg or more of L-dopa (levodopa) per day. The use of potent dopaminergic agents to stimulate emergence from an altered consciousness state, such as a coma, is disclosed.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: May 17, 2011
    Assignee: NeuroHealing Pharmaceuticals, Inc.
    Inventors: Daniel E. Katzman, Elkan R. Gamzu, Neal M. Farber, Esteban A. Fridman, Marcelo Merello
  • Publication number: 20090123545
    Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.
    Type: Application
    Filed: July 21, 2006
    Publication date: May 14, 2009
    Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu
  • Publication number: 20080102102
    Abstract: The invention provides methods and compositions comprising an anti-cholinergic agent for decreasing saliva production and treating sialorrhea.
    Type: Application
    Filed: January 19, 2006
    Publication date: May 1, 2008
    Applicant: NEUROHEALING PHARMACEUTICALS, INC.
    Inventors: Marcelo Merello, Neal M. Farber, Eyal S. Ron